Cargando…
Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study
OBJECTIVE: To retrospectively analyze the safety and long-term clinical efficacy of gelatin sponge microparticles combined with the chemotherapy drug pirarubicin for hepatic transcatheter arterial chemoembolization (GSMs-TACE) in order to treat breast cancer liver metastasis (BCLM). METHODS: Twenty-...
Autores principales: | Zhao, Guang Sheng, Liu, Song, Liu, Ying, Ma, Jian, Wang, Ruo Yu, Bian, Jie, Zhou, Jun, Wu, Jian Lin, Zhang, Yue Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380398/ https://www.ncbi.nlm.nih.gov/pubmed/34419064 http://dx.doi.org/10.1186/s12957-021-02332-0 |
Ejemplares similares
-
Transcatheter Arterial Chemoembolization With Gelatin Sponge Microparticles Treated for BCLC Stage B Hepatocellular Carcinoma: A Single Center Retrospective Study
por: Kamran, Asad Ullah, et al.
Publicado: (2015) -
Clinical application of gelatin sponge microparticles-transcatheter arterial chemoembolization combined with synchronous antigen-presenting dendritic cell sequential reinfusion for treatment of advanced large liver cancer: A single-center, prospective, non-randomized, controlled trial
por: Zhao, Guang Sheng, et al.
Publicado: (2022) -
Changes in the frequency of myeloid-derived suppressor cells after transarterial chemoembolization with gelatin sponge microparticles for hepatocellular carcinoma
por: Yue, Yuanxun, et al.
Publicado: (2019) -
Gelatin sponge microparticles for transarterial chemoembolization combined with regorafenib in hepatocellular carcinoma: a single-center retrospective study
por: Su, Mao, et al.
Publicado: (2022) -
Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer
por: Zhang, Chao, et al.
Publicado: (2022)